Children treated with anti-TNF therapy at risk for weight gain, obesity

Children with inflammatory bowel disease who receive anti-tumor necrosis factor treatment were more likely to see BMI levels increase and incur a risk for obesity, according to a presentation at Crohn’s and Colitis Congress.“Crohn’s disease patients with anti-TNF exposure have a significant increase in BMI z score over time as compared to those unexposed and while for most of our patients, this increase in BMI z score is likely restorative, there is a subset of Crohn’s disease patients where anti-TNF therapy may be a risk factor for excessive weight gain and obesity,”Read More

Share on facebook
Share on twitter
Share on linkedin